Synopsys Reports Tomorrow but the Real Earnings Date Was Three Quarters Ago
Synopsys Inc (SNPS) reports fiscal Q2 2026 earnings after market close on May 27, 2026, with Wall Street expecting $2.24 per share on revenue of approximately $2.25 billion. The central question: can the electronic design automation leader sustain momentum from its recent Ansys acquisition integration while navigating a 13.51% year-over-year earnings decline against a backdrop of strengthening technical signals and rising analyst conviction?
Part 1: Earnings Preview
Synopsys is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property, serving chip designers and manufacturers worldwide. The company's tools are essential for designing and verifying complex integrated circuits, with recent expansion into engineering simulation through its Ansys acquisition.
Synopsys reports after market close on May 27, 2026, with analysts expecting $2.24 per share and revenue of $2.25 billion (up 40.23% year-over-year). The most recently reported quarter (Q1 FY2026) delivered $2.69 per share, beating estimates by 10.70%. However, the current quarter's consensus represents a 13.51% decline compared to the $2.59 reported in the same quarter last year (Q2 FY2025), reflecting integration costs and operational adjustments.
Three key themes define this earnings story:
Ansys Integration Execution: The $35 billion Ansys acquisition closed in 2025, and investors are scrutinizing how effectively Synopsys is integrating the engineering simulation business. The company reiterated full-year revenue guidance of $9.61 billion at the midpoint, including $2.9 billion of expected Ansys contribution, but near-term margin pressure from integration costs is weighing on quarterly EPS comparisons. Management's ability to demonstrate synergies and cross-selling opportunities will be critical.
AI-Driven Design Tool Demand: Synopsys is positioned at the intersection of AI chip design and AI-powered EDA tools. Demand for advanced design solutions supporting AI accelerators, high-performance computing, and next-generation semiconductors remains robust. The company's AI-enhanced verification and design platforms are seeing strong adoption, but investors want confirmation that this momentum is translating into sustained bookings growth.
Export Control and Geopolitical Headwinds: The company has explicitly noted that financial targets assume no further changes to export control restrictions or U.S. government Entity List restrictions. Any escalation in semiconductor trade restrictions—particularly affecting China-related revenue—could pressure results. Management commentary on geographic revenue mix and regulatory risk will be closely watched.
Analyst sentiment has deteriorated slightly over the past month, with the average recommendation slipping from 4.38 to 4.29, though the consensus remains firmly in buy territory. The $2.0 billion stock repurchase authorization announced in February signals management confidence, but the 13.5% earnings decline estimate suggests Wall Street is pricing in near-term headwinds before the Ansys integration fully pays off.
Part 2: Historical Earnings Performance
Synopsys has demonstrated consistent earnings execution over the past four quarters, beating analyst estimates in three of the last four reports. The most recent quarter (Q1 FY2026) delivered $2.69 per share against a $2.43 estimate, a solid 10.70% beat. This followed an even stronger Q4 FY2025 surprise of 31.94% ($1.90 actual vs. $1.44 estimate), suggesting the company has been managing integration complexities better than Wall Street initially feared.
The pattern shows volatility in both directions. Q3 FY2025 produced a notable 16.67% miss ($2.30 vs. $2.76 estimate), the only significant shortfall in recent history, while Q2 FY2025 beat by 7.92%. The Q3 miss coincided with the early stages of Ansys integration and likely reflected conservative guidance as management navigated the combination.
The trend is constructive: after the Q3 stumble, Synopsys has delivered two consecutive double-digit beats, indicating improving visibility and execution. However, the upcoming quarter faces a tougher comparison—the $2.59 reported in Q2 FY2025 was a strong result, and the current $2.24 estimate reflects Wall Street's expectation that integration costs will temporarily compress margins. Investors should watch whether management can deliver another upside surprise or if the year-over-year decline proves deeper than anticipated.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Apr 2025 | $2.40 | $2.59 | +7.92% | Beat |
| Jul 2025 | $2.76 | $2.30 | -16.67% | Miss |
| Oct 2025 | $1.44 | $1.90 | +31.94% | Beat |
| Jan 2026 | $2.43 | $2.69 | +10.70% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Synopsys reports after market close, meaning Day 0 captures anticipatory trading before results drop, while Day +1 reflects the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-25 | +$8.45 (+1.92%) | $14.33 (3.25%) | -$23.17 (-5.16%) | $20.22 (4.50%) |
| 2025-12-10 | +$9.98 (+2.14%) | $16.77 (3.60%) | +$1.43 (+0.30%) | $26.62 (5.59%) |
| 2025-09-09 | -$4.71 (-0.77%) | $12.39 (2.03%) | -$216.59 (-35.84%) | $48.80 (8.07%) |
| 2025-05-28 | -$49.36 (-9.64%) | $69.99 (13.68%) | -$7.44 (-1.61%) | $50.30 (10.88%) |
| 2025-02-26 | +$12.51 (+2.73%) | $14.46 (3.16%) | -$15.75 (-3.35%) | $33.95 (7.22%) |
| 2024-12-04 | +$17.81 (+3.12%) | $15.22 (2.67%) | -$72.71 (-12.37%) | $45.78 (7.79%) |
| 2024-08-21 | +$7.65 (+1.37%) | $11.76 (2.11%) | -$16.62 (-2.94%) | $38.75 (6.86%) |
| 2024-05-22 | +$1.60 (+0.28%) | $11.70 (2.05%) | +$13.17 (+2.30%) | $37.00 (6.45%) |
| Avg Abs Move | 2.75% | 4.07% | 7.98% | 7.17% |
Post-earnings price action for Synopsys has been highly volatile and directionally unpredictable. The average absolute Day 0 move is 2.75%, while Day +1 averages a much larger 7.98%, indicating that the real reaction typically comes the session after results are digested. The Day +1 range averages 7.17%, suggesting wide intraday swings as investors reassess guidance and management commentary.
Recent history shows dramatic outliers: the September 2025 report triggered a catastrophic 35.84% decline on Day +1, while the May 2025 report saw a 9.64% drop on Day 0. Conversely, several quarters produced modest gains or small losses. The lack of consistent directional bias—with both sharp selloffs and rallies in the dataset—means investors should prepare for significant volatility in either direction. The most recent report (February 2026) saw a 1.92% Day 0 gain followed by a 5.16% Day +1 decline, reinforcing the pattern of delayed, amplified reactions.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/29/26 (DTE 3) |
| Expected Move | $40.80 (7.63%) |
| Expected Range | $493.76 to $575.36 |
| Implied Volatility | 118.74% |
The options market is pricing a 7.63% expected move for this earnings event, which is slightly below the stock's average historical Day +1 move of 7.98% but well above the Day 0 average of 2.75%. This suggests options traders are anticipating meaningful volatility, though not quite at the extreme levels seen in some recent quarters. The implied range of $493.76 to $575.36 reflects significant uncertainty around both integration progress and guidance.
Part 3: What Analysts Are Saying
Analyst sentiment remains bullish but cautious, with an average recommendation of 4.29 (between Buy and Strong Buy) and a mean price target of $540.33—implying just 1.08% upside from the current price of $534.56. The consensus has deteriorated slightly over the past month, slipping from 4.38, suggesting some analysts are taking a more conservative stance heading into the report.
The rating breakdown shows 14 Strong Buys, 1 Moderate Buy, 5 Holds, and 1 Strong Sell among 21 analysts covering the stock. This represents a modest shift from a month ago, when 15 analysts held Strong Buy ratings and only 4 were at Hold. The migration from Strong Buy to Hold reflects growing caution around near-term margin pressure and integration execution risk, though the overwhelming majority still view the long-term story favorably.
The price target range is wide: the high estimate of $650.00 implies 21.6% upside, while the low target of $425.00 suggests 20.5% downside risk. This dispersion reflects divergent views on how quickly Ansys synergies will materialize and whether AI-driven EDA demand can offset integration headwinds. The mean target of $540.33 sitting just above the current price suggests the Street is largely neutral on valuation at these levels, waiting for clearer evidence that the integration is on track before raising targets meaningfully.
Part 4: Technical Picture
Synopsys is entering earnings with strengthening technical momentum and broad-based support across timeframes. The Barchart Technical Opinion currently stands at 56% Buy, a significant improvement from 40% Buy last week and a dramatic reversal from 8% Sell a month ago. This rapid shift reflects accelerating bullish momentum as the stock has broken out above key resistance levels.
Timeframe Analysis:
- Short-term (100% Buy): Maximum bullish signal indicates powerful near-term momentum heading into the earnings event, suggesting strong institutional accumulation
- Medium-term (Hold): Neutral reading suggests the intermediate trend is consolidating recent gains, with the stock digesting its rally before the next directional move
- Long-term (50% Buy): Moderate buy signal reflects improving longer-term trend structure as the stock establishes higher support levels
Trend Characteristics: The trend is showing Average strength but is Strengthening, indicating that while momentum is building, the move is not yet overextended—a constructive setup for potential continuation if earnings deliver positive surprises.
The stock is trading at $534.56, positioned above all major moving averages: the 5-day ($511.22), 10-day ($508.94), 20-day ($503.42), 50-day ($456.88), 100-day ($459.37), and 200-day ($470.93). This alignment is strongly bullish, with the stock sitting roughly 17% above its 50-day moving average and 13.5% above the critical 200-day line.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $511.22 | 50-Day MA | $456.88 |
| 10-Day MA | $508.94 | 100-Day MA | $459.37 |
| 20-Day MA | $503.42 | 200-Day MA | $470.93 |
The technical setup is supportive but elevated heading into earnings. The stock has rallied sharply in recent weeks, creating a cushion above all moving averages and generating strong short-term momentum signals. However, the 100% Buy short-term reading and rapid sentiment improvement suggest the stock may be vulnerable to profit-taking if results disappoint or guidance underwhelms. The $503-$511 zone (20-day and 5-day moving averages) represents initial support, while a break below the $456-$459 range (50-day and 100-day averages) would signal a more significant technical breakdown. Conversely, a strong earnings beat could propel the stock toward the $575 upper bound of the options-implied range, with the $540 analyst target serving as an intermediate resistance level.